Navigation Links
Depomed To Present At Piper Jaffray 2013 Healthcare Conference
Date:12/2/2013

NEWARK, Calif., Dec. 2, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Piper Jaffray 25th Annual Healthcare Conference at The New York Palace Hotel in New York City.

The presentation at the Piper conference is scheduled for 12:10 pm EST (9:10 am PST) on Tuesday, December 3, 2013.  The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com.  A recording of the webcast will be archived for 30 days on the company's website.

About Depomed

Depomed, Inc. is a specialty pharmaceutical company that commercializes products for pain and neurology related disorders. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults. Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and other products and product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology. Additional information about Depomed may be found at www.depomed.com.

CONTACT: August J. Moretti  
Depomed, Inc. 650-462-5900
amoretti@depomed.com

 


'/>"/>
SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Depomed Reports Third Quarter 2013 Financial Results
2. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
3. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
4. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
5. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
6. Depomed Reports Second Quarter 2013 Financial Results
7. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
8. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
9. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
10. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
11. Depomed To Present At Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... , January 13, 2017 ... to see how they have fared at yesterday,s closing ... Galena Biopharma Inc. (NASDAQ: GALE ), and ... companies harness cellular and biomolecular processes to develop technologies ... our environmental footprint, feed the hungry, use less and ...
(Date:1/13/2017)... YORK , January 13, 2017 ... legal cannabis industry, with several states voting in favor of ... , the largest Cannabis market in the U.S. In addition, ... $1 billion mark in annual cannabis products sales. The ArcView ... according to which the legal cannabis sales in the U.S. ...
(Date:1/13/2017)...   JDRF , the leading global organization ... to announce that after more than a decade ... Medicaid Services (CMS) has recognized continuous glucose monitoring ... in making diabetes treatment decisions as durable medical ... for coverage under Medicare. JDRF has been the ...
Breaking Medicine Technology:
(Date:1/15/2017)... Santa Rosa, CA (PRWEB) , ... January 15, ... ... to nominate their choice of best physicians in eight Bay Area counties for ... selected by the healthcare research company managing the award process. Results were announced ...
(Date:1/14/2017)... ... January 13, 2017 , ... According to a December 9 ... may lower the risk of type 2 diabetes, Alzheimer’s, and cardiovascular disease. Southern ... wellness benefits linked to a Mediterranean diet are only some of the many ...
(Date:1/13/2017)... ... 2017 , ... A January 10 article in the Daily Star ... publication, with an emphasis on some new techniques that the publication says are becoming ... more casually to his patients and colleagues as Dr. J, comments that the best ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive teeth are about ... they brush their teeth. Sadly, most dental hygiene products in the market contain chemical ... For these people, continuing their daily oral care routine to keep their teeth white ...
(Date:1/13/2017)... ... January 13, 2017 , ... The ... and most comprehensive franchise ranking. Recognized by entrepreneurs and franchisors as a top ... exceptional performance in areas including financial strength and stability, growth rate, and brand ...
Breaking Medicine News(10 mins):